TY  - GEN
AU  - Floc'h,Nicolas
AU  - Martin,Matthew J
AU  - Riess,Jonathan W
AU  - Orme,Jonathan P
AU  - Staniszewska,Anna D
AU  - Ménard,Ludovic
AU  - Cuomo,Maria Emanuela
AU  - O'Neill,Daniel J
AU  - Ward,Richard A
AU  - Finlay,M Raymond V
AU  - McKerrecher,Darren
AU  - Cheng,Mingshan
AU  - Vang,Daniel P
AU  - Burich,Rebekah A
AU  - Keck,James G
AU  - Gandara,David R
AU  - Mack,Philip C
AU  - Cross,Darren A E
TI  - Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions
SN  - 1538-8514
PY  - 2019///0708
KW  - Acrylamides
KW  - Aniline Compounds
KW  - Animals
KW  - COS Cells
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Chlorocebus aethiops
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Exons
KW  - genetics
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Mice, SCID
KW  - Mutation
KW  - Piperazines
KW  - pharmacology
KW  - Protein Kinase Inhibitors
KW  - Xenograft Model Antitumor Assays
KW  - methods
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1158/1535-7163.MCT-17-0758
ER  -